chr14-20198116-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001386033.1(OR11G2):āc.679A>Gā(p.Arg227Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001386033.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR11G2 | NM_001386033.1 | c.679A>G | p.Arg227Gly | missense_variant | 2/2 | ENST00000641879.2 | |
OR11G2 | NM_001005503.2 | c.679A>G | p.Arg227Gly | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR11G2 | ENST00000641879.2 | c.679A>G | p.Arg227Gly | missense_variant | 2/2 | NM_001386033.1 | P1 | ||
OR11G2 | ENST00000641682.1 | c.679A>G | p.Arg227Gly | missense_variant | 2/2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 152014Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251482Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135908
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461892Hom.: 0 Cov.: 35 AF XY: 0.00000963 AC XY: 7AN XY: 727248
GnomAD4 genome AF: 0.0000724 AC: 11AN: 152014Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74244
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2022 | The c.781A>G (p.R261G) alteration is located in exon 1 (coding exon 1) of the OR11G2 gene. This alteration results from a A to G substitution at nucleotide position 781, causing the arginine (R) at amino acid position 261 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at